Skip to main content

Beneficial ownership — 13D / 13G

85,706 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC EYE National Vision Holdings, Inc. 13G/A 12.6% 2y
Sakellaris George P AMRC Ameresco, Inc. 13G/A 39.5% 2y
American Century Investment Management, Inc. FBP First Bancorp 13G/A 4.8% 2y
BASSWOOD CAPITAL MANAGEMENT, L.L.C. ESQ Esquire Financial Holdings, Inc. 13G/A 4.78% 2y
Topline Capital Management, LLC IDN Intellicheck, Inc. 13G/A 6.6% 2y
PRIMECAP MANAGEMENT CO/CA/ FLEX Flex Ltd. 13G/A 10.42% 2y
NEUBERGER BERMAN GROUP LLC STVN Stevanato Group S.p.A. 13G 9.93% 2y
BIOGEN INC. DNLI Denali Therapeutics Inc. 13G/A 1% 2y
EARNEST PARTNERS LLC AIN Albany International Corp 13G/A 8.1% 2y
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO NUE Nucor Corp 13G/A 8.1% 2y
Mei Mei Hu VAXX Vaxxinity, Inc. Class A Common Stock 13G/A 70.5% 2y
BRANDES INVESTMENT PARTNERS, LP EGRX Eagle Pharmaceuticals, Inc. 13G 5.74% 2y
GQG Partners LLC APP AppLovin Corp 13G 9.71% 2y
FIRST WILSHIRE SECURITIES MANAGEMENT INC MTRX Matrix Service Co 13G/A 8% 2y
RWWM, Inc. DJCO Daily Journal Corp 13G/A 23.53% 2y
JANUS HENDERSON GROUP PLC ETNB 89bio, Inc. Common Stock 13G/A 9.6% 2y
Carlyle Group Inc. GTM ZoomInfo Technologies Inc. 13G/A 9% 2y
LeMaitre George W LMAT Lemaitre Vascular Inc 13G/A 10.3% 2y
LMR Partners LLP IXAQF IX Acquisition Corp. 13G/A 1.3% 2y
MORGAN STANLEY BCAT BlackRock Capital Allocation Term Trust 13G/A 5.7% 2y
American Century Investment Management, Inc. KLIC Kulicke & Soffa Industries Inc 13G/A 5.4% 2y
Polar Asset Management Partners Inc. FRLA Fortune Rise Acquisition Corporation Class A Common Stock 13G/A 0% 2y
Topline Capital Management, LLC OPXS Optex Systems Holdings Inc 13G/A 11.8% 2y
Charles Gillespie GRSD GRANDSTAND Ltd 13G/A 13.5% 2y
ARISTEIA CAPITAL, L.L.C. TGAA Target Global Acquisition I Corp. Class A Ordinary Share 13G/A 0% 2y
Durable Capital Partners LP DUOL Duolingo, Inc. 13G/A 8.9% 2y
Contrarius Investment Management Ltd WW Ww International, Inc. 13G 9.4% 2y
ARISTEIA CAPITAL, L.L.C. HCVI Hennessy Capital Investment Corp. VI Class A Common Stock 13G/A 0% 2y
DRIVEN EQUITY SUB LLC DRVN Driven Brands Holdings Inc. 13G/A 42% 2y
FULLER & THALER ASSET MANAGEMENT, INC. WTM White Mountains Insurance Group Ltd 13G/A 5.06% 2y
MORGAN STANLEY ARQT Arcutis Biotherapeutics, Inc. 13G 6.5% 2y
JANUS HENDERSON GROUP PLC MIR Mirion Technologies, Inc. 13G/A 4.3% 2y
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC BWXT BWX Technologies, Inc. 13G/A 5.1% 2y
Howard Todd Horberg EQS Equus Total Return, Inc. 13G/A 5.21% 2y
Taconic Capital Advisors LP PRIAF Prime Impact Acquisition I 13G/A 0% 2y
Patrick G. Ryan RYAN Ryan Specialty Holdings, Inc. 13G/A 55.32% 2y
Polar Asset Management Partners Inc. VEEA Veea Inc. 13G/A 2.7% 2y
Pathfinder Bank Employee Stock Ownership Plan Trust PBHC Pathfinder Bancorp, Inc. 13G/A 6.2% 2y
Altshuler Shaham Ltd KEN Kenon Holdings Ltd. 13G/A 6.4% 2y
CHARLES SCHWAB INVESTMENT MANAGEMENT INC IVC Invacare Corporation 13G/A 0% 2y
FIFTHDELTA Ltd INVZ Innoviz Technologies Ltd. 13G/A 5.29% 2y
MPM BioVentures 2018 LLC DYN Dyne Therapeutics, Inc. 13G/A 4.3% 2y
Lou Reese VAXX Vaxxinity, Inc. Class A Common Stock 13G/A 9.4% 2y
OR Cantor Fitzgerald Securities PFTA Perception Capital Corp. III Class A Ordinary Share 13G/A 0% 2y
Rubric Capital Management LP OVID Ovid Therapeutics Inc. 13G/A 7.52% 2y
American Century Investment Management, Inc. BBSI Barrett Business Services Inc 13G/A 3.68% 2y
Bristol Investment Fund, Ltd. RSSS Research Solutions, Inc. 13D/A 4.2% 2y
NEUBERGER BERMAN GROUP LLC UFPT Ufp Technologies Inc 13G/A 9.96% 2y
JANE STREET GROUP, LLC DGNU Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares 13G/A 0% 2y
Contrarius Investment Management Ltd DO Diamond Offshore Drilling, Inc. 13G/A 1.9% 2y